Stephen Martin Courtney

This inventor holds 52 USPTO granted patents and 6 published patent applications, plus 6 CIPO patents and 20 EPO patents, primarily in Nitroxyl Donors (CPC class C07D). Top assignees: Cardioxyl Pharmaceuticals, Inc., Johns Hopkins University, Chdi Foundation, Inc.. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Martin Courtney. Retrieved from https://idiyas.com/inventor/stephen-martin-courtney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 52 (Patent Applications = 6)

% Patents Active = 84.6

CIPO Patents = 6

EPO Patents = 20 (Patent Applications = 30)

Average Co-Inventor Count = 5.2

ph-index = 14

Forward Citations = 462(Granted Patents)

Forward Citations (Not Self Cited) = 138(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Marcham, Oxon, GB (1999)
Stanford in the Vale, GB (2014 - 2015)
Oxfordshire, GB (2006 - 2022)
Abingdon, GB (2008 - 2023)

Company Filing History:

37 out of 37

Cardioxyl Pharmaceuticals, Inc.

patents

18 out of 3,806

Johns Hopkins University

patents

9 out of 56

Chdi Foundation, Inc.

patents

4. 2 out of 15

Oxford Glycosciences (UK) Ltd

Oxford Glycoscience (UK) Ltd.

patent

8. 1 out of 29

Vifor (International) Ag

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Areas of Expertise:

Nitroxyl Donors

Kynurenine Inhibitors

Pharmaceutical Compositions

N-Hydroxylsulfonamide Derivatives

Pyrazolone Derivatives

Therapeutic Index

Transglutaminase Inhibitors

Nitroso Compounds

Bis-Acylated Hydroxylamines

Sulfonaminoquinoline Antagonists

Kynurenine-3-Monooxygenase

N-Hydroxymethanesulfonamide

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12186301 - Nitroxyl donors with improved therapeutic index (2025-01-07),

2. 11786501 - Nitroxyl donors with improved therapeutic index (2023-10-17),

3. 11306056 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors (2022-04-19),

4. 11304924 - Pharmaceutical compositions comprising nitroxyl donors (2022-04-19),

5. 11273143 - Nitroxyl donors with improved therapeutic index (2022-03-15),

6. 10829445 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors (2020-11-10),

7. 10792273 - Nitroxyl donors with improved therapeutic index (2020-10-06),

8. 10730828 - N-hydroxylsulfonamide derivatives as nitroxyl donors (2020-08-04),

9. 10723704 - Pyrazolone derivatives as nitroxyl donors (2020-07-28),

10. 10548872 - Pharmaceutical compositions comprising nitroxyl donors (2020-02-04),

11. 10517847 - Nitroxyl donors with improved therapeutic index (2019-12-31),

12. 10487049 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors (2019-11-26),

13. 10245249 - Pharmaceutical compositions comprising nitroxyl donors (2019-04-02),

14. 10213408 - Nitroxyl donors with improved therapeutic index (2019-02-26),

15. 10179765 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors (2019-01-15),

Title: Stephen Martin Courtney - Innovative Inventor from Abingdon, GB

Introduction: Stephen Martin Courtney is a renowned inventor based in Abingdon, GB, known for his groundbreaking contributions to various industries.

Latest Patents: Stephen Martin Courtney holds several patents in the fields of technology, healthcare, and sustainability, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Stephen Martin Courtney has established himself as a pioneer in inventing cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Stephen Martin Courtney has collaborated with leading companies, research institutions, and universities to bring his inventions to life and make a lasting impact on society.

Conclusion: Stephen Martin Courtney's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.